Clinical data | |
---|---|
Other names | 4-hydroxy-N,N-dimethyltryptamine |
Routes of administration | Oral, IV |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 1-3 hours[2] |
Excretion | Urine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.543 |
Chemical and physical data | |
Formula | C12H16N2O |
Molar mass | 204.273 g·mol−1 |
3D model (JSmol) | |
Melting point | 173 to 176 °C (343 to 349 °F) |
| |
| |
(what is this?) (verify) |
Psilocin (also known as 4-HO-DMT, 4-hydroxy DMT, psilocine, psilocyn, or psilotsin) is a substituted tryptamine alkaloid and a serotonergic psychedelic substance. It is present in most psychedelic mushrooms[3] together with its phosphorylated counterpart psilocybin. Psilocin is a Schedule I drug under the Convention on Psychotropic Substances.[4] Acting on the 5-HT2A serotonin receptors, psilocin’s psychedelic effects are directly correlated with the drug's occupancy at these receptor sites.[5] The subjective mind-altering effects of psilocin are highly variable and are said to resemble those of LSD and DMT.
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search